S. ÖZMEN Et Al. , "Neutrophil-Lymphocyte Ratio (NLR) and Platelet -Lymphocyte Ratio (PLR) may be superior to C-Reactive Protein (CRP) for predicting the occurrence of differentiated thyroid cancer," 18th European Congress of Endocrinology , vol.41, 2016
ÖZMEN, S. Et Al. 2016. Neutrophil-Lymphocyte Ratio (NLR) and Platelet -Lymphocyte Ratio (PLR) may be superior to C-Reactive Protein (CRP) for predicting the occurrence of differentiated thyroid cancer. 18th European Congress of Endocrinology .
ÖZMEN, S., TİMUR, Ö., ÇALIK, İ., ALTINKAYNAK, K., ZİPAK, E., ŞİMŞEK, E., ... YILDIZ, F.(2016). Neutrophil-Lymphocyte Ratio (NLR) and Platelet -Lymphocyte Ratio (PLR) may be superior to C-Reactive Protein (CRP) for predicting the occurrence of differentiated thyroid cancer . 18th European Congress of Endocrinology
ÖZMEN, Sevilay Et Al. "Neutrophil-Lymphocyte Ratio (NLR) and Platelet -Lymphocyte Ratio (PLR) may be superior to C-Reactive Protein (CRP) for predicting the occurrence of differentiated thyroid cancer," 18th European Congress of Endocrinology, 2016
ÖZMEN, Sevilay Et Al. "Neutrophil-Lymphocyte Ratio (NLR) and Platelet -Lymphocyte Ratio (PLR) may be superior to C-Reactive Protein (CRP) for predicting the occurrence of differentiated thyroid cancer." 18th European Congress of Endocrinology , 2016
ÖZMEN, S. Et Al. (2016) . "Neutrophil-Lymphocyte Ratio (NLR) and Platelet -Lymphocyte Ratio (PLR) may be superior to C-Reactive Protein (CRP) for predicting the occurrence of differentiated thyroid cancer." 18th European Congress of Endocrinology .
@conferencepaper{conferencepaper, author={Sevilay ÖZMEN Et Al. }, title={Neutrophil-Lymphocyte Ratio (NLR) and Platelet -Lymphocyte Ratio (PLR) may be superior to C-Reactive Protein (CRP) for predicting the occurrence of differentiated thyroid cancer}, congress name={18th European Congress of Endocrinology}, city={}, country={}, year={2016}}